drugset / Trial / NCT04637633
Topical Cyclosporine-A for Management of Epiphora
NaSingle-groupOpen-labelTreatment
Summary
to investigate the clinical outcomes and tolerances of Cyclosporine A (CsA) in treating epiphora in eyes with acquired punctum stenosis
Timeline
- Start
- 2020-08-15
- Primary completion
- 2020-10-30
- Completion
- 2020-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.05 % | Topical |